Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-009013
Filing Date
2018-02-09
Accepted
2018-02-09 19:29:48
Documents
1
Period of Report
2018-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5049
  Complete submission text file 0001209191-18-009013.txt   6403
Mailing Address 60 WEST 66TH STREET, 26A NEW YORK NY 10023
Business Address
Bishop Hans Edgar (Reporting) CIK: 0001480212 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 18593529

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)